Bellerophon Therapeutics, Inc. of WARREN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-10-11. The offering totals $23.4M, of which $23.4M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 41 people.
| Name | Role | Location |
|---|---|---|
| Naseem P Amin | Director | Warren, NJ |
| Scott P Bruder | Director | Warren, NJ |
| Mary Ann P Cloyd | Director | Warren, NJ |
| Jens P Luehring | Director | Warren, NJ |
| Andre V Moura | Director | New York, NY |
| Jonathan M Peacock | Director | Thousand Oaks, CA |
| Daniel V Tasse | Director | Warren, NJ |
| Fabian Tenenbaum | Director | Warren, NJ |
| Adam B Weinstein | Director | New York, NY |
| Martin A Dekker | Executive Officer | Warren, NJ |
| Amy A Edmonds | Executive Officer | Warren, NJ |
| Peter B Fernandes | Executive Officer | Warren, NJ |
| Deborah A Quinn | Executive Officer | Warren, NJ |
| Megan A Schoeps | Executive Officer | Warren, NJ |
| Parag A Shah | Executive Officer | Warren, NJ |
| Fabian Tenenbaum | Executive Officer | Warren, NJ |
| Adam Weinstein | Director | New York, NY |
| David Abrams | Executive Officer | TORONTO, A6 |
| MATTHEW HOLT | Director | Palm Beach, FL |
| Daniel Tasse | Director | Chatillon, I0 |
| Daniel Tasse | Executive Officer | Chatillon, I0 |
| Bryan Roberts | Director | Boulder, CO |
| Andre Moura | Director | NEW YORK, NY |
| Robert Nelsen | Director | Seattle, WA |
| Howard Pien | Director | Harrison, NY |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2017-05-19 | D | $1.6M | $1.6M |
| 2014-07-02 | D | $1 | $1 |
| 2014-02-21 | D | $1 | $1 |